Analyzing Medication Adherence Patterns Among Type 2 Diabetes Patients in Thi-Qar, Iraq: A Cross-Sectional Study

This research investigates the adherence levels to diabetes treatment among patients and explores the factors influencing adherence, glycemic control, and the occurrence of diabetes-related complications. A cross-sectional study involving 296 diabetes patients was conducted to evaluate their demogra...

Full description

Saved in:
Bibliographic Details
Main Authors: Adel Gassab Mohammed, Nassar Taha Yaseen, Dheyaa K. AlWaeli
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/jdr/6659722
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849309546792615936
author Adel Gassab Mohammed
Nassar Taha Yaseen
Dheyaa K. AlWaeli
author_facet Adel Gassab Mohammed
Nassar Taha Yaseen
Dheyaa K. AlWaeli
author_sort Adel Gassab Mohammed
collection DOAJ
description This research investigates the adherence levels to diabetes treatment among patients and explores the factors influencing adherence, glycemic control, and the occurrence of diabetes-related complications. A cross-sectional study involving 296 diabetes patients was conducted to evaluate their demographic and clinical profiles, treatment strategies, and adherence levels using the eight-item Morisky Medication Adherence Scale (MMAS-8). Statistical analyses identified variables affecting adherence and their relationships with glycemic control and complications. The study population comprised 56% men, with an average age of 49.4 years. Obesity was observed in 24.3% of participants, while the median disease duration was 5 years. The average HbA1c level was 8.4%. Microvascular complications were present in 48.6% of patients, and 18.2% experienced macrovascular complications. Most patients were prescribed oral antidiabetic medications (OAD), with 25% receiving insulin therapy. Adherence rates were suboptimal, with only 3.4% achieving good adherence, 30.4% moderate adherence, and 66.2% poor adherence. Men had higher rates of poor adherence compared to women (72.3% vs. 58.5%). Interestingly, adherence was better in patients with a longer disease duration and a higher body mass index (BMI). The study further examined adherence’s impact on glycemic outcomes, finding that poor adherence strongly correlated with elevated HbA1c levels. Among individuals with HbA1c≥7%, 70.5% exhibited poor adherence, whereas 40% of patients with good adherence still had suboptimal glycemic control. Conversely, among those with HbA1c<7%, 24.5% demonstrated poor adherence compared to 40% with good adherence. Random blood sugar (RBS) levels were significantly higher in poorly adherent patients (237 mg/dL) versus those with good adherence (141 mg/dL). Although adherence was not statistically linked to complication prevalence, patients with reported adherence challenges were more prone to both microvascular and macrovascular complications. Different treatment regimens were also analyzed, revealing that sulfonylureas (SUs) were associated with poor adherence (85%), while sodium–glucose cotransporter 2 inhibitors (SGLT2i) showed better adherence rates (16.7%). Missed doses were strongly linked to poor glycemic outcomes but had a lesser impact on complication development. These findings underscore the need for individualized strategies to enhance adherence and optimize glycemic control, ultimately reducing diabetes-related complications.
format Article
id doaj-art-d03c9d5f689d4719a079f69d09ac6f6d
institution Kabale University
issn 2314-6753
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-d03c9d5f689d4719a079f69d09ac6f6d2025-08-20T03:54:07ZengWileyJournal of Diabetes Research2314-67532025-01-01202510.1155/jdr/6659722Analyzing Medication Adherence Patterns Among Type 2 Diabetes Patients in Thi-Qar, Iraq: A Cross-Sectional StudyAdel Gassab Mohammed0Nassar Taha Yaseen1Dheyaa K. AlWaeli2Department of MedicineFaiha Specialized DiabetesDepartment of MedicineThis research investigates the adherence levels to diabetes treatment among patients and explores the factors influencing adherence, glycemic control, and the occurrence of diabetes-related complications. A cross-sectional study involving 296 diabetes patients was conducted to evaluate their demographic and clinical profiles, treatment strategies, and adherence levels using the eight-item Morisky Medication Adherence Scale (MMAS-8). Statistical analyses identified variables affecting adherence and their relationships with glycemic control and complications. The study population comprised 56% men, with an average age of 49.4 years. Obesity was observed in 24.3% of participants, while the median disease duration was 5 years. The average HbA1c level was 8.4%. Microvascular complications were present in 48.6% of patients, and 18.2% experienced macrovascular complications. Most patients were prescribed oral antidiabetic medications (OAD), with 25% receiving insulin therapy. Adherence rates were suboptimal, with only 3.4% achieving good adherence, 30.4% moderate adherence, and 66.2% poor adherence. Men had higher rates of poor adherence compared to women (72.3% vs. 58.5%). Interestingly, adherence was better in patients with a longer disease duration and a higher body mass index (BMI). The study further examined adherence’s impact on glycemic outcomes, finding that poor adherence strongly correlated with elevated HbA1c levels. Among individuals with HbA1c≥7%, 70.5% exhibited poor adherence, whereas 40% of patients with good adherence still had suboptimal glycemic control. Conversely, among those with HbA1c<7%, 24.5% demonstrated poor adherence compared to 40% with good adherence. Random blood sugar (RBS) levels were significantly higher in poorly adherent patients (237 mg/dL) versus those with good adherence (141 mg/dL). Although adherence was not statistically linked to complication prevalence, patients with reported adherence challenges were more prone to both microvascular and macrovascular complications. Different treatment regimens were also analyzed, revealing that sulfonylureas (SUs) were associated with poor adherence (85%), while sodium–glucose cotransporter 2 inhibitors (SGLT2i) showed better adherence rates (16.7%). Missed doses were strongly linked to poor glycemic outcomes but had a lesser impact on complication development. These findings underscore the need for individualized strategies to enhance adherence and optimize glycemic control, ultimately reducing diabetes-related complications.http://dx.doi.org/10.1155/jdr/6659722
spellingShingle Adel Gassab Mohammed
Nassar Taha Yaseen
Dheyaa K. AlWaeli
Analyzing Medication Adherence Patterns Among Type 2 Diabetes Patients in Thi-Qar, Iraq: A Cross-Sectional Study
Journal of Diabetes Research
title Analyzing Medication Adherence Patterns Among Type 2 Diabetes Patients in Thi-Qar, Iraq: A Cross-Sectional Study
title_full Analyzing Medication Adherence Patterns Among Type 2 Diabetes Patients in Thi-Qar, Iraq: A Cross-Sectional Study
title_fullStr Analyzing Medication Adherence Patterns Among Type 2 Diabetes Patients in Thi-Qar, Iraq: A Cross-Sectional Study
title_full_unstemmed Analyzing Medication Adherence Patterns Among Type 2 Diabetes Patients in Thi-Qar, Iraq: A Cross-Sectional Study
title_short Analyzing Medication Adherence Patterns Among Type 2 Diabetes Patients in Thi-Qar, Iraq: A Cross-Sectional Study
title_sort analyzing medication adherence patterns among type 2 diabetes patients in thi qar iraq a cross sectional study
url http://dx.doi.org/10.1155/jdr/6659722
work_keys_str_mv AT adelgassabmohammed analyzingmedicationadherencepatternsamongtype2diabetespatientsinthiqariraqacrosssectionalstudy
AT nassartahayaseen analyzingmedicationadherencepatternsamongtype2diabetespatientsinthiqariraqacrosssectionalstudy
AT dheyaakalwaeli analyzingmedicationadherencepatternsamongtype2diabetespatientsinthiqariraqacrosssectionalstudy